HI HR197

Requests the FDA eliminate its one-year blood donor deferral policy for men who have sex with men (MSM), which has been in place since December 21, 2015.

Urges the FDA to adopt individual risk assessment screening for all blood donors instead of lifestyle-based deferrals specific to MSM.

Argues that 15 countries including Italy, Spain, and Mexico have lifted or maintain no deferral policies for MSM without significant impact on HIV transmission rates.

Notes that a 2014 study found lifting MSM donor restrictions could increase the U.S. blood supply by 2-4 percent, potentially saving more lives.

Directs certified copies of the resolution be sent to the FDA Commissioner, Blood Products Advisory Committee, and the Advisory Committee on Blood and Tissue Safety and Availability.